Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia
Launched by KYUNGPOOK NATIONAL UNIVERSITY HOSPITAL · Apr 9, 2015
Trial Information
Current as of June 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Nonsmoking women (ASA physical status of I or II) scheduled for gynecologic surgery under general anesthesia and postoperative analgesia with a PCA device were included
- Exclusion Criteria:
- • known hypersensitivity to study medication; the use of antiemetics within 24 hours before surgery; the presence of gastrointestinal, renal, hepatic, or psychiatric disease.
About Kyungpook National University Hospital
Kyungpook National University Hospital is a leading medical institution in South Korea, dedicated to advancing healthcare through innovative research and clinical excellence. Affiliated with Kyungpook National University, the hospital serves as a hub for clinical trials and medical studies, focusing on diverse therapeutic areas to enhance patient outcomes. With a commitment to fostering collaboration between healthcare professionals and researchers, the institution aims to contribute significantly to the global medical community by translating scientific discoveries into effective treatments and care practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials